RRRs for Use of Delayed Antibiotic Prescribing During Project Intervention and Postintervention Periods Relative to Baseline
. | All Participating Clinicians . | Subset Participating in Postintervention Phase . | ||
---|---|---|---|---|
RRR (95% CI) . | P . | RRR (95% CI) . | P . | |
Baseline Nov–Dec 2018 | Referent | — | Referent | — |
January 2019 | 3.27 (1.73–6.19) | <0.01 | 2.12 (1.0–4.49) | 0.498 |
February 2019 | 7.24 (4.08–12.86) | <0.01 | 4.13 (2.14–7.95) | <0.01 |
March 2019 | 7.47 (4.20–13.31) | <0.01 | 5.30 (2.80–10.2) | <0.01 |
April 2019 | 10.15 (5.71–18.04) | <0.01 | 8.24 (4.38–15.50) | <0.01 |
May 2019 | 11.53 (6.46–20.56) | <0.01 | 9.80 (5.23–18.37) | <0.01 |
June 2019 | 8.96 (4.68–17.17) | <0.01 | 7.53 (3.66–15.51) | <0.01 |
3 mo postintervention September 2019 | —a | — | 8.46 (4.18–17.11) | <0.01 |
6 mo postintervention December 2019 | — | — | 6.69 (3.53–12.65) | <0.01 |
. | All Participating Clinicians . | Subset Participating in Postintervention Phase . | ||
---|---|---|---|---|
RRR (95% CI) . | P . | RRR (95% CI) . | P . | |
Baseline Nov–Dec 2018 | Referent | — | Referent | — |
January 2019 | 3.27 (1.73–6.19) | <0.01 | 2.12 (1.0–4.49) | 0.498 |
February 2019 | 7.24 (4.08–12.86) | <0.01 | 4.13 (2.14–7.95) | <0.01 |
March 2019 | 7.47 (4.20–13.31) | <0.01 | 5.30 (2.80–10.2) | <0.01 |
April 2019 | 10.15 (5.71–18.04) | <0.01 | 8.24 (4.38–15.50) | <0.01 |
May 2019 | 11.53 (6.46–20.56) | <0.01 | 9.80 (5.23–18.37) | <0.01 |
June 2019 | 8.96 (4.68–17.17) | <0.01 | 7.53 (3.66–15.51) | <0.01 |
3 mo postintervention September 2019 | —a | — | 8.46 (4.18–17.11) | <0.01 |
6 mo postintervention December 2019 | — | — | 6.69 (3.53–12.65) | <0.01 |
—, not applicable.
Some clinicians did not participate in the post-intervention phase.